A quick screen for companies with growing dividends turned up five well known companies to most dividend growth investors -- Automatic Data Processing, Becton Dickinson and Company, Johnson and Johnson, Lear Corporation and Occidental Petroleum. Owning any of these over the last few years would have been very lucrative. Below is an overview of each of these companies along with some fundamentals and a couple of charts. Each of these are worth consideration and further research. The more investors know about companies like these, the better they become as investors.
Automatic Data Processing, Inc. provides worldwide business process outsourcing services. The company operates through two segments, Employer Services and Professional Employer Organization (PEO) Services. The Employer Services segment offers a range of business outsourcing and technology-enabled human capital management (HCM) solutions, including payroll services, benefits administration services, talent management, human resources management solutions, time and attendance management solutions, insurance services, retirement services, and tax and compliance solutions. This segment's integrated HCM solutions include RUN Powered by ADP, ADP Workforce Now, ADP Vantage HCM, and ADP GlobalView, which assist employers of all sizes in all stages of the employment cycle from recruitment to retirement; and ADP SmartCompliance and ADP Health Compliance. The PEO Services segment provides a human resources (HR) outsourcing solution through a co-employment model to small and mid-sized businesses. This segment offers ADP TotalSource that provides various HR management services and employee benefits functions, such as HR administration, employee benefits, and employer liability management into a single-source solution. The company was founded in 1949 and is headquartered in Roseland, New Jersey.
(Summary) (Company) (Chart)
| 6 December 2016 Price $96.00 1yr Target $93.36 Analysts 14 Dividend $2.28 Payout Ratio 68.26% 1yr Cap Gain -2.75% Yield 2.37% 1yr Tot Return -0.38% P/E 28.77 PEG 2.52 Beta 0.82 | EPS (ttm) $3.34 EPS next yr $4.07 Forward P/E 23.58 EPS next 5yr 11.44% 1yr Price Support $46.56 Market Cap $43.55 Bil Revenues $11.87 Bil Earnings $1.52 Bil Profit Margin 12.80% Quick Ratio 1.10 Current Ratio 1.10 Debt/Equity 0.47 | 1yr RevGR 6.66% 3yr RevGR 7.23% 5yr RevGR 3.47% 1yr EarnGR 6.55% 3yr EarnGR 3,95% 5yr EarnGR 5.21% 1yr DivGR 9.93% 3yr DivGR 11.53% 5yr DivGR 10.75% ROA 3.60% ROE 35.00% |
 ADP Monthly Chart |  ADP Dividend History |
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
(Summary) (Company) (Chart)
| 6 December 2016 Price $164.75 1yr Target $188.57 Analysts 14 Dividend $2.92 Payout Ratio 64.88% 1yr Cap Gain 14.45% Yield 1.77% 1yr Tot Return 16.22% P/E 36.64 PEG 3.50 Beta 1.01 | EPS (ttm) $4.50 EPS next yr $10.51 Forward P/E 16.68 EPS next 5yr 15.68% 1yr Price Support $164.79 Market Cap $35.19 Bil Revenues $12.48 Bil Earnings $975.00 Mil Profit Margin 7.81% Quick Ratio 1.10 Current Ratio 1.40 Debt/Equity 1.51 | 1yr RevGR 21.40% 3yr RevGR 15.55% 5yr RevGR 10.48% 1yr EarnGR 34.02% 3yr EarnGR -11.45% 5yr EarnGR -4.40% 1yr DivGR 10.00% 3yr DivGR 9.95% 5yr DivGR 9.98% ROA 3.80% ROE 12.80% |
 BDX Monthly Chart |  BDX Dividend History |
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women's health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
(Summary) (Company) (Chart)
| 6 December 2016 Price $112.06 1yr Target $126.26 Analysts 19 Dividend $3.20 Payout Ratio 56.04% 1yr Cap Gain 12.67% Yield 2.85% 1yr Tot Return 15.52% P/E 19.64 PEG 3.00 Beta 0.73 | EPS (ttm) $5.71 EPS next yr $7.14 Forward P/E 15.69 EPS next 5yr 6.55% 1yr Price Support $46.76 Market Cap $306.10 Bil Revenues $71.60 Bil Earnings $15.94 Bil Profit Margin 22.26% Quick Ratio 2.40 Current Ratio 2.70 Debt/Equity 0.37 | 1yr RevGR -5.73% 3yr RevGR 1.37% 5yr RevGR 2.61% 1yr EarnGR -3.86% 3yr EarnGR 12.25% 5yr EarnGR 2.77% 1yr DivGR 6.88% 3yr DivGR 7.04% 5yr DivGR 6.93% ROA 11.60% ROE 22.10% |
 JNJ Monthly Chart |  JNJ Dividend History |
Lear Corporation designs, develops, engineers, manufactures, assembles, and supplies automotive seating, electrical distribution systems, and related components primarily to automotive original equipment manufacturers worldwide. It operates in two segments, Seating and Electrical. The Seating segment provides seat systems and related components, such as leather and fabric products, seat trim covers, recliner mechanisms, seat tracks, seat structures and mechanisms, seat foams, and headrests primarily for automobiles and light trucks, compact cars, and sport utility vehicles. The Electrical segment offers electrical distribution systems and components for managing power and distributing signals within the vehicle for traditional vehicle architectures, as well as high power and hybrid electric systems. This segment's products include wiring harnesses, terminals and connectors, and high power components for hybrid and electric vehicles; and electronic modules, such as body control modules, gateway modules, junction boxes, lighting control modules, and audio amplifiers. It also provides wireless communication modules, including passive entry, remote keyless entry, and dual range/dual function remote keyless entry systems. Lear Corporation was founded in 1917 and is headquartered in Southfield, Michigan.
(Summary) (Company) (Chart)
| 6 December 2016 Price $132.91 1yr Target $138.93 Analysts 15 Dividend $1.20 Payout Ratio 9.11% 1yr Cap Gain 4.52% Yield 0.90% 1yr Tot Return 5.42% P/E 10.10 PEG 0.73 Beta 1.25 | EPS (ttm) $13.16 EPS next yr $14.59 Forward P/E 9.11 EPS next 5yr 13.80% 1yr Price Support $201.34 Market Cap $9.40 Bil Revenues $18.64 Bil Earnings $980.50 Mil Profit Margin 5.25% Quick Ratio 1.10 Current Ratio 1.40 Debt/Equity 0.63 | 1yr RevGR 2.73% 3yr RevGR 7.64% 5yr RevGR 8.78% 1yr EarnGR 16.52% 3yr EarnGR -9.21% 5yr EarnGR 18.81% 1yr DivGR 25.00% 3yr DivGR 21.08% 5yr DivGR --- ROA 9.90% ROE 32.50% |
 LEA Monthly Chart |  LEA Dividend History |
Occidental Petroleum Corporation engages in the acquisition, exploration, and development of oil and gas properties in the United States and internationally. The company operates in three segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. The Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; vinyls comprising vinyl chloride monomer and polyvinyl chloride; and other chemicals, such as resorcinol. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also trades around its assets consisting of transportation and storage capacity, as well as oil, NGLs, gas, and other commodities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.
(Summary) (Company) (Chart)
| 6 December 2016 Price $70.41 1yr Target $77.04 Analysts 24 Dividend $3.04 Payout Ratio --- 1yr Cap Gain 9.41% Yield 4.31% 1yr Tot Return 13.72% P/E --- PEG --- Beta 0.86 | EPS (ttm) $-8.17 EPS next yr $1.36 Forward P/E 51.92 EPS next 5yr --- 1yr Price Support --- Market Cap $54.13 Bil Revenues $10.21 Bil Earnings $-6.23 Bil Profit Margin --- Quick Ratio 1.40 Current Ratio 1.50 Debt/Equity 0.37 | 1yr RevGR --- 3yr RevGR --- 5yr RevGR --- 1yr EarnGR --- 3yr EarnGR --- 5yr EarnGR --- 1yr DivGR 5.53% 3yr DivGR 12.20% 5yr DivGR 15.81% ROA -12.90% ROE -23.40% |
 OXY Monthly Chart |  OXY Dividend History |
Print 
PDF
RSS Feed
